Lensar (LNSR) Change in Receivables (2019 - 2026)
Lensar (LNSR) reported Change in Receivables of -$1.5 million for Q1 2026, down 301.48% year-over-year from $743000.0 in Q1 2025, and down 409.94% quarter-over-quarter from $483000.0 in Q4 2025.
Lensar (LNSR) Change in Receivables (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Change in Receivables data on file, last reported at -$1.5 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$1.5 million, down 301.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 169.51% YoY), and the FY2025 annual result was $211000.0, down 90.36% from the prior year.
- Change in Receivables eased to -$1.5 million in Q1 2026 per LNSR's latest filing, from $483000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $2.5 million in Q4 2022 and troughed at -$1.9 million in Q2 2025.
- A 5-year average of $16823.5 and a median of $155000.0 in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables sank 1191.58% in 2022, then jumped 5615.38% in 2025.
- A 5-year view of Change in Receivables shows it stood at $2.5 million in 2022, then tumbled by 93.81% to $155000.0 in 2023, then soared by 1070.97% to $1.8 million in 2024, then plunged by 73.39% to $483000.0 in 2025, then plunged by 409.94% to -$1.5 million in 2026.
- Business Quant data shows LNSR's Change in Receivables at -$1.5 million in Q1 2026, $483000.0 in Q4 2025, and $921000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Lensar | 70.05 Mn | 70.34 Mn | 6.38 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 743,000.00 |
| Mar 31, 2025 | 743,000.00 |
| Dec 31, 2024 | 1.82 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Dec 31, 2023 | 155,000.00 |